| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ABL1 | CBL | ENSGGOP00000010326 | ENSGGOP00000017349 | Tyrosine-protein kinase. | Cbl proto-oncogene. | 0.993 |
| ABL1 | CRK | ENSGGOP00000010326 | ENSGGOP00000006608 | Tyrosine-protein kinase. | CRK proto-oncogene, adaptor protein. | 0.993 |
| ABL1 | CRKL | ENSGGOP00000010326 | ENSGGOP00000038775 | Tyrosine-protein kinase. | Uncharacterized protein. | 0.984 |
| ABL1 | EGFR | ENSGGOP00000010326 | ENSGGOP00000041101 | Tyrosine-protein kinase. | Receptor protein-tyrosine kinase. | 0.845 |
| ABL1 | GRB2 | ENSGGOP00000010326 | ENSGGOP00000005990 | Tyrosine-protein kinase. | Growth factor receptor bound protein 2. | 0.992 |
| ABL1 | PIK3R1 | ENSGGOP00000010326 | ENSGGOP00000050489 | Tyrosine-protein kinase. | Phosphoinositide-3-kinase regulatory subunit 1. | 0.878 |
| ABL1 | VAV1 | ENSGGOP00000010326 | ENSGGOP00000011974 | Tyrosine-protein kinase. | Vav guanine nucleotide exchange factor 1. | 0.810 |
| CBL | ABL1 | ENSGGOP00000017349 | ENSGGOP00000010326 | Cbl proto-oncogene. | Tyrosine-protein kinase. | 0.993 |
| CBL | CRK | ENSGGOP00000017349 | ENSGGOP00000006608 | Cbl proto-oncogene. | CRK proto-oncogene, adaptor protein. | 0.997 |
| CBL | CRKL | ENSGGOP00000017349 | ENSGGOP00000038775 | Cbl proto-oncogene. | Uncharacterized protein. | 0.987 |
| CBL | EGFR | ENSGGOP00000017349 | ENSGGOP00000041101 | Cbl proto-oncogene. | Receptor protein-tyrosine kinase. | 0.999 |
| CBL | G3RV02_GORGO | ENSGGOP00000017349 | ENSGGOP00000019631 | Cbl proto-oncogene. | SH3 domain containing kinase binding protein 1. | 0.995 |
| CBL | GRB2 | ENSGGOP00000017349 | ENSGGOP00000005990 | Cbl proto-oncogene. | Growth factor receptor bound protein 2. | 0.997 |
| CBL | MET | ENSGGOP00000017349 | ENSGGOP00000041736 | Cbl proto-oncogene. | Hepatocyte growth factor receptor; Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of thes [...] | 0.995 |
| CBL | PIK3R1 | ENSGGOP00000017349 | ENSGGOP00000050489 | Cbl proto-oncogene. | Phosphoinositide-3-kinase regulatory subunit 1. | 0.987 |
| CBL | SPRY2 | ENSGGOP00000017349 | ENSGGOP00000010870 | Cbl proto-oncogene. | Sprouty RTK signaling antagonist 2. | 0.994 |
| CBL | VAV1 | ENSGGOP00000017349 | ENSGGOP00000011974 | Cbl proto-oncogene. | Vav guanine nucleotide exchange factor 1. | 0.995 |
| CRK | ABL1 | ENSGGOP00000006608 | ENSGGOP00000010326 | CRK proto-oncogene, adaptor protein. | Tyrosine-protein kinase. | 0.993 |
| CRK | CBL | ENSGGOP00000006608 | ENSGGOP00000017349 | CRK proto-oncogene, adaptor protein. | Cbl proto-oncogene. | 0.997 |
| CRK | CRKL | ENSGGOP00000006608 | ENSGGOP00000038775 | CRK proto-oncogene, adaptor protein. | Uncharacterized protein. | 0.987 |
